POORLY DIFFERENTIATED THYROID CARCINOMA

POORLY DIFFERENTIATED THYROID CARCINOMA was reported 10 times

POORLY DIFFERENTIATED THYROID CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CERITINIB 1 0.0004
1 SORAFENIB 6 0.0003
2 FREMANEZUMAB-VFRM 1 0.0001
3 PAZOPANIB HYDROCHLORIDE 2 0.0001
4 LENVATINIB 2 0.0001
5 LITHIUM CARBONATE 1 0.0001
6 PEMETREXED DISODIUM 2 0.0001
7 PACLITAXEL 2 0.0000
8 PEMBROLIZUMAB 2 0.0000
9 EMPAGLIFLOZIN 1 0.0000
10 VALACYCLOVIR HYDROCHLORIDE 1 0.0000
11 ORAL SEMAGLUTIDE 1 0.0000
12 DENOSUMAB 2 0.0000
13 ESOMEPRAZOLE MAGNESIUM 1 0.0000
14 METFORMIN ER 500 MG 1 0.0000